ES2130083B1 - Procedimiento para la obtencion de los enantiomeros de cizolirtina. - Google Patents

Procedimiento para la obtencion de los enantiomeros de cizolirtina.

Info

Publication number
ES2130083B1
ES2130083B1 ES009701728A ES9701728A ES2130083B1 ES 2130083 B1 ES2130083 B1 ES 2130083B1 ES 009701728 A ES009701728 A ES 009701728A ES 9701728 A ES9701728 A ES 9701728A ES 2130083 B1 ES2130083 B1 ES 2130083B1
Authority
ES
Spain
Prior art keywords
cizolirtine
enantiomers
procedure
obtaining
enantiomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009701728A
Other languages
English (en)
Other versions
ES2130083A1 (es
Inventor
Antoni Torrens-Jover
Jordi Firgola-Constansa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES009701728A priority Critical patent/ES2130083B1/es
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Priority to DE69809282T priority patent/DE69809282T2/de
Priority to PT98935042T priority patent/PT1029852E/pt
Priority to CA002299447A priority patent/CA2299447C/en
Priority to DK98935042T priority patent/DK1029852T3/da
Priority to ES98935042T priority patent/ES2187044T3/es
Priority to EP98935042A priority patent/EP1029852B1/en
Priority to PCT/ES1998/000223 priority patent/WO1999007684A1/es
Priority to JP2000506188A priority patent/JP2001512718A/ja
Priority to AT98935042T priority patent/ATE227272T1/de
Priority to AU84426/98A priority patent/AU8442698A/en
Priority to US09/485,023 priority patent/US6118009A/en
Publication of ES2130083A1 publication Critical patent/ES2130083A1/es
Application granted granted Critical
Publication of ES2130083B1 publication Critical patent/ES2130083B1/es
Priority to NO20000560A priority patent/NO314499B1/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedimiento papa la obtención de los enantiómeros de cizolirtina. El procedimiento comprende (a) la reducción de enantioselectiva de una cetona proquiral (III) mediante en empleo de un reductor y un catalizador quiral derivados de boro en un disolvente o mezcla de disolventes anhidros para formar un enantiómero de un alcohol (II), y (b) la alquilación de (II), en condiciones de transferencia de fase, opcionalmente previo aislamiento y purificación del mismo, con 2-cloro-N, N-dimetiletilamina, para formar un enantiómero de (I). La cizolirtina tiene propiedades analgésicas. Fórmulas (I), (II) y (III).
ES009701728A 1997-08-04 1997-08-04 Procedimiento para la obtencion de los enantiomeros de cizolirtina. Expired - Fee Related ES2130083B1 (es)

Priority Applications (13)

Application Number Priority Date Filing Date Title
ES009701728A ES2130083B1 (es) 1997-08-04 1997-08-04 Procedimiento para la obtencion de los enantiomeros de cizolirtina.
AU84426/98A AU8442698A (en) 1997-08-04 1998-07-31 Process for obtaining enantiomers of cis-olirtine
CA002299447A CA2299447C (en) 1997-08-04 1998-07-31 Procedure for obtaining the enantiomers of cyzolirtine
DK98935042T DK1029852T3 (da) 1997-08-04 1998-07-31 Fremgangsmåde til udvinding af enantiomerer af cis-olirtin
ES98935042T ES2187044T3 (es) 1997-08-04 1998-07-31 Procedimiento para la obtencion de enantiomeros de cizolirtina.
EP98935042A EP1029852B1 (en) 1997-08-04 1998-07-31 Process for obtaining enantiomers of cis-olirtine
DE69809282T DE69809282T2 (de) 1997-08-04 1998-07-31 Verfahren zur gewinnung von enantiomeren von cis-olirtin
JP2000506188A JP2001512718A (ja) 1997-08-04 1998-07-31 シゾリルチンの鏡像体を得るための方法
AT98935042T ATE227272T1 (de) 1997-08-04 1998-07-31 Verfahren zur gewinnung von enantiomeren von cis- olirtin
PT98935042T PT1029852E (pt) 1997-08-04 1998-07-31 Processo para obtencao de enantiomeros de cis-olirtina
US09/485,023 US6118009A (en) 1997-08-04 1998-07-31 Process for obtaining enantiomers of cis-olirtine
PCT/ES1998/000223 WO1999007684A1 (es) 1997-08-04 1998-07-31 Procedimiento para la obtencion de los enantiomeros de cizolirtina
NO20000560A NO314499B1 (no) 1997-08-04 2000-02-03 Fremgangsmåte for å oppnå enantiomerer av cis-olirtin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701728A ES2130083B1 (es) 1997-08-04 1997-08-04 Procedimiento para la obtencion de los enantiomeros de cizolirtina.

Publications (2)

Publication Number Publication Date
ES2130083A1 ES2130083A1 (es) 1999-06-16
ES2130083B1 true ES2130083B1 (es) 2000-01-16

Family

ID=8300306

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009701728A Expired - Fee Related ES2130083B1 (es) 1997-08-04 1997-08-04 Procedimiento para la obtencion de los enantiomeros de cizolirtina.
ES98935042T Expired - Lifetime ES2187044T3 (es) 1997-08-04 1998-07-31 Procedimiento para la obtencion de enantiomeros de cizolirtina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES98935042T Expired - Lifetime ES2187044T3 (es) 1997-08-04 1998-07-31 Procedimiento para la obtencion de enantiomeros de cizolirtina.

Country Status (12)

Country Link
US (1) US6118009A (es)
EP (1) EP1029852B1 (es)
JP (1) JP2001512718A (es)
AT (1) ATE227272T1 (es)
AU (1) AU8442698A (es)
CA (1) CA2299447C (es)
DE (1) DE69809282T2 (es)
DK (1) DK1029852T3 (es)
ES (2) ES2130083B1 (es)
NO (1) NO314499B1 (es)
PT (1) PT1029852E (es)
WO (1) WO1999007684A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
WO2005097192A2 (en) * 2004-04-05 2005-10-20 Laboratorios Del Dr. Esteve, S.A. Active substance combination of a carbinol compound and an opioid
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
EP1671968A1 (en) * 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1671953A1 (en) * 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining cizolirtine and its enantiomers
WO2006063861A1 (en) * 2004-12-17 2006-06-22 Laboratorios Del Dr. Esteve, S.A. Process for obtaining cizolirtine and its enantiomers
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
US20100291151A1 (en) * 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
DE102010056283A1 (de) 2010-12-24 2012-06-28 Volkswagen Ag Wärmeübertragungssystem
CN108558695A (zh) * 2018-05-15 2018-09-21 浙江华贝药业有限责任公司 2，2，2-三氟-n-[(1s，4s)-4-羟基四氢萘-1-基]-乙酰胺制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943635A (en) * 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
NZ249302A (en) * 1992-05-14 1996-11-26 Pfizer 4,5-diphenyl-1,3,2-oxazaborolidine derivatives and their use as catalysts in reduction of ketones to chiral alcohols
US5442118A (en) * 1994-04-22 1995-08-15 Sepracor, Inc. Asymmetric synthesis of (R)- and (S)-arylethanolamines from iminoketones

Also Published As

Publication number Publication date
CA2299447C (en) 2007-05-29
ES2187044T3 (es) 2003-05-16
DE69809282T2 (de) 2003-09-11
NO20000560D0 (no) 2000-02-03
EP1029852A1 (en) 2000-08-23
WO1999007684A1 (es) 1999-02-18
JP2001512718A (ja) 2001-08-28
DE69809282D1 (de) 2002-12-12
ES2130083A1 (es) 1999-06-16
CA2299447A1 (en) 1999-02-18
NO20000560L (no) 2000-03-29
DK1029852T3 (da) 2003-02-24
AU8442698A (en) 1999-03-01
EP1029852B1 (en) 2002-11-06
ATE227272T1 (de) 2002-11-15
US6118009A (en) 2000-09-12
PT1029852E (pt) 2003-03-31
NO314499B1 (no) 2003-03-31

Similar Documents

Publication Publication Date Title
ES2130083B1 (es) Procedimiento para la obtencion de los enantiomeros de cizolirtina.
ES2196544T3 (es) Dispersion acuosa de ligante para las lacas de aplicacion electroforetica cationica por inmersion.
BR0012434A (pt) Composto, processo para a preparação do mesmo, uso de um composto, composição farmacêutica.
BR9815026B1 (pt) processo para preparar um composto, e, composto.
BR9708047A (pt) Processo para a preparação de nitrobifenilas
Yu et al. Enantioselective Synthesis of 2‐Bromomethyl Indolines via BINAP (S)‐Catalyzed Bromoaminocyclization of Allyl Aniline
Wang et al. Destruction and construction: application of dearomatization strategy in aromatic carbon–nitrogen bond functionalization
KR960702468A (ko) 거울상선택적 옥사자보로리딘 촉매(Enantioselective oxazaborolidine catalysts)
BR9903573A (pt) Processo para preparação de haloformiminas, e, compostos de haloforminina
ES2096973T3 (es) Fosfazenos que contienen radicales organicos de silicio, proceso para su preparacion, y su empleo.
Kim et al. Concise Asymmetric Total Synthesis of ent‐Ancistrocladinium A
Rulev et al. Direct Access to Cumbersome Aminated Quaternary Centers by Hyperbaric Aza‐Michael Additions
McSweeney et al. The asymmetric alkylation of dimethylhydrazones; intermolecular chirality transfer using sparteine as chiral ligand
AR043825A1 (es) Procesos de preparacion de 5-(haloacetil)-8-(oxisustituidos)-(1h)-quinolin-2-onas
BR0314966A (pt) Processo para preparar um composto, e, composto
PT909751E (pt) Um processo para a preparacao de esteres do acido cinamico
BR0111317A (pt) Processo para preparar compostos, composto, sistema de catalisador, e, usos de um composto e de um sistema de catalisador
Yoshida et al. Chemoselective Catalytic Asymmetric Synthesis of Functionalized Aminals Through the Umpolung Organocascade Reaction of α‐Imino Amides
Tohma et al. Stereoselective nucleophilic addition with a new chiral template and its application to the synthesis of optically active α-arylglycine derivatives
Cherednichenko et al. Enantiomeric N‐tert‐Butylsulfinyl Imines of Methyl Trifluoropyruvate: Promising Building Blocks in Asymmetric Synthesis of α‐Trifluoromethylated Amino Acids and Derivatives
Magnus et al. Non-oxidative methodology for the synthesis of vinblastine and vincristine models
BR9909151A (pt) processos para preparação de intermediários
ES485645A1 (es) Un procedimiento mejorado para preparar n-fenil-n'-alcohil- fenilendiamina
KOHRA et al. Reaction of α-Oxoketene Dithioacetals with Arylamines in the Presence of BF3-OEt2 for the Synthesis of Ketene S, N-Acetals
AR015771A1 (es) Proceso para la preparacion de r-(+)-6-carboxamido-3-n-metilamino-1,2,3,4-tetrahidrocarbazol, compuestos intermediarios y el uso del acido l-piroglutamico.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990616

Kind code of ref document: A1

Effective date: 19990616

FD2A Announcement of lapse in spain

Effective date: 20180807